K
Kent W. Jones
Researcher at LDS Hospital
Publications - 42
Citations - 1553
Kent W. Jones is an academic researcher from LDS Hospital. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 21, co-authored 42 publications receiving 1520 citations. Previous affiliations of Kent W. Jones include National Institutes of Health & United States Department of Veterans Affairs.
Papers
More filters
Journal Article
Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.
Elizabeth H. Hammond,Yowell Rl,Nunoda S,Ronald L. Menlove,Dale G. Renlund,Michael R. Bristow,Kent W. Jones,John B. O'Connell +7 more
TL;DR: It is concluded that immunofluorescence should be routinely done on all heart biopsies for the first month after transplantation, because patients with vascular (humoral) rejection cannot be reliably identified by any other means.
Journal ArticleDOI
Bypass of superior vena cava. Fifteen years' experience with spiral vein graft for obstruction of superior vena cava caused by benign disease.
TL;DR: The data show that bypass of the obstructed superior vena cava with a spiral vein graft relieves inferior vena caval syndrome and demonstrate long-term patency of the graft.
Journal ArticleDOI
The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients.
Ensley Rd,Michael R. Bristow,Olsen Sl,David O. Taylor,Elizabeth H. Hammond,John B. O'Connell,Diane Dunn,Linda Osburn,Kent W. Jones,R S Kauffman,Dale G. Renlund +10 more
TL;DR: It is concluded that mycophenolate mofetil is safe and well tolerated in cardiac transplant recipients, is less myelosuppressive than azathioprine, and appears to be at least equipotent to azathoprine.
Journal ArticleDOI
Cardiac transplantation in situs inversus.
TL;DR: Transplantation of the heart was successfully performed in a patient with situs inversus of the viscera and atria with systemic venous reconstruction, which reconstructed venous passageways have remained patent and unobstructed for 1 1/2 years after the operation.
Journal ArticleDOI
Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome clinical investigation and reports
Heath U. Jones,Joseph B. Muhlestein,Kent W. Jones,Tami L Bair,Farangis Lavasani,Mahtab Sohrevardi,Benjamin D. Horne,Donald B. Doty,Donald L Lappe +8 more
TL;DR: The preoperative use of enoxaparin compared with UFH in patients presenting with an ACS who undergo open-heart surgery during the same hospitalization is associated with a significantly increased incidence of re-exploration for postoperative bleeding.